H-CYTE, Inc. (HCYT)

OTCMKTS: HCYT · Delayed Price · USD
0.0200
+0.0004 (2.05%)
Jul 5, 2022 10:52 AM - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016201520142013
Revenue
1.612.158.357.880.210000
Cost of Revenue
0.70.772.052.370.160000
Gross Profit
0.911.386.295.520.040000
Selling, General & Admin
2.77.2420.519.015.595.264.6600.58
Research & Development
01.15000.491.130.871.020.09
Other Operating Expenses
3.490.080.83-40.030.010.951.920
Operating Expenses
6.198.4821.345.016.116.46.482.940.67
Operating Income
-5.29-7.09-30.56-4.73-6.06-12.86-6.47-2.94-0.67
Interest Expense
-0.181.460.30.160.40.460.0500
Other Expense / Income
0.490.630.750.33-0.39-0.460.8900
Pretax Income
-4.8-6.46-29.81-4.39-6.46-13.31-5.580-0.67
Net Income
-4.8-6.46-29.81-4.39-6.46-16.23-6.520-0.67
Shares Outstanding (Basic)
111111962319131189
Shares Outstanding (Diluted)
111111962319131189
EPS (Basic)
-0.03-0.06-0.34-0.23-0.34-1.22-0.60-0.37-0.07
EPS (Diluted)
-0.03-0.06-0.34-0.23-0.34-1.22-0.60-0.37-0.07
Free Cash Flow Per Share
-0.04-0.07-0.13-0.10-0.29-0.42-0.55
EBITDA
-4.96-4.92-28.67-4.21-6.03-12.66-5.110-0.67